Evaluation of an Alternative Injection Paradigm for OnabotulinumtoxinA (BOTOX®) in the Treatment of Overactive Bladder in Patients With Urinary Incontinence

NCT03052764 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Urinary Bladder, Overactive
Urinary Incontinence

Interventions

BIOLOGICAL: onabotulinumtoxinA
DRUG: Placebo (saline)

Sponsor

Allergan